Products RU
Menu
Product Portfolio Pharmacovigilance & Drugs Safety
+7 (495) 721-36-97 info@akrikhin.ru
Press Center
You can contact our
Corporate Communications

Department by phone at +7 495 721-36-97

or by email to pr@akrikhin.ru
All
year
all
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
News
all
Year
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
AKRIKHIN and Active Component deepen strategic partnership 18.06.2025
More than 20 million Russians1 have been given the opportunity to hand over blisters for recycling 29.04.2025
Akrikhin and PSK Pharma are introducing a domestic analogue of a highly sought-after1 drug for the treatment of diabetes into the retail channel 19.03.2025
Akrikhin produces an original non-steroidal anti-inflammatory drug 04.02.2025
Akrikhin produces an affordable1 and fully localized analogue of a popular cardiac drug 06.12.2024
Akrikhin became the winner of the international competition GxP-Profi 2024 19.11.2024
Show more Show more
Warning!

According to current legislation, the information provided in this section is intended exclusively for certified professionals in the fields of medicine and pharmaceuticals.

Are you a certified healthcare professional?

No Yes